Plain-English translation of NCT07253129 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing two different types of stem cell transplants for people with peripheral T-cell lymphoma (a type of blood cancer) that has partially improved after standard chemotherapy. One approach uses stem cells collected from a matched donor, while the other uses the patient's own previously collected stem cells. The study aims to determine which approach works better and is safer for patients in this situation.
Peripheral T-cell lymphoma is difficult to treat, and many patients don't completely respond to standard chemotherapy alone. This trial exists to find out whether adding a stem cell transplant—and which type—offers the best chance of long-term remission and survival for these patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be assigned to receive one of two types of stem cell transplants based on donor availability and your preference. You will undergo baseline tests including blood work, imaging scans, and bone marrow evaluation. Then you will receive conditioning chemotherapy followed by infusion of stem cells (either your own or from a donor). You will be monitored closely during recovery with regular follow-up visits, blood tests, and imaging studies to track how well the transplant is working and to watch for any side effects.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
China